Recent Finacing
Recent Raise
PhaseV provides an AI/ML clinical-development platform offering Bayesian/adaptive trial optimization, causal ML for heterogeneous treatment effects and disease modeling, plus operations tools for site selection, monitoring, virtual control arms.
